Clinical Trial Update: Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two liraglutide formulations in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED